TY - JOUR
T1 - Hematologic manifestations of celiac disease
AU - Halfdanarson, Thorvardur R.
AU - Litzow, Mark R.
AU - Murray, Joseph A.
PY - 2007/1/15
Y1 - 2007/1/15
N2 - Celiac disease is a common systemic disorder that can have multiple hematologic manifestations. Patients with celiac disease may present to hematologists for evaluation of various hematologic problems prior to receiving a diagnosis of celiac disease. Anemia secondary to malabsorption of iron, folic acid, and/or vitamin B12 is a common complication of celiac disease and many patients have anemia at the time of diagnosis. Celiac disease may also be associated with thrombocytosis, thrombocytopenia, leukopenia, venous thromboembolism, hyposplenism, and IgA deficiency. Patients with celiac disease are at increased risk of being diagnosed with lymphoma, especially of the T-cell type. The risk is highest for enteropathy-type T-cell lymphoma (ETL) and B-cell lymphoma of the gut, but extraintestinal lymphomas can also be seen. ETL is an aggressive disease with poor prognosis, but strict adherence to a gluten-free diet may prevent its occurrence.
AB - Celiac disease is a common systemic disorder that can have multiple hematologic manifestations. Patients with celiac disease may present to hematologists for evaluation of various hematologic problems prior to receiving a diagnosis of celiac disease. Anemia secondary to malabsorption of iron, folic acid, and/or vitamin B12 is a common complication of celiac disease and many patients have anemia at the time of diagnosis. Celiac disease may also be associated with thrombocytosis, thrombocytopenia, leukopenia, venous thromboembolism, hyposplenism, and IgA deficiency. Patients with celiac disease are at increased risk of being diagnosed with lymphoma, especially of the T-cell type. The risk is highest for enteropathy-type T-cell lymphoma (ETL) and B-cell lymphoma of the gut, but extraintestinal lymphomas can also be seen. ETL is an aggressive disease with poor prognosis, but strict adherence to a gluten-free diet may prevent its occurrence.
UR - http://www.scopus.com/inward/record.url?scp=33846310035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846310035&partnerID=8YFLogxK
U2 - 10.1182/blood-2006-07-031104
DO - 10.1182/blood-2006-07-031104
M3 - Review article
C2 - 16973955
AN - SCOPUS:33846310035
SN - 0006-4971
VL - 109
SP - 412
EP - 421
JO - Blood
JF - Blood
IS - 2
ER -